Paper41997307
Regulation of PSAT1 and PHGDH by m6A in endocrine-resistant breast cancer cells.
Piell KM and 10 others. Biochim Biophys Acta Mol Basis Dis, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Regulation of PSAT1 and PHGDH by m6A in endocrine-resistant breast cancer cells. Papers, record 41997307. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41997307
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Adenosine | Major topic |
| Drug Resistance, Neoplasm | Major topic |
| Phosphoglycerate Dehydrogenase | Major topic |
| Humans | |
| Female | |
| MicroRNAs | |
| RNA Methylation | |
| Gene Expression Regulation, Neoplastic | |
| Cell Line, Tumor | |
| Methyltransferases | |
| Epitranscriptome |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P30 ES030283 | NIEHS NIH HHS | United States | P30ES030283 | PubMed | NIH RePORTER |
| T35 DK072923 | NIDDK NIH HHS | United States | T35DK072923 | PubMed | NIH RePORTER |
References96
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28522855 | Phosphoserine aminotransferase 1 is associated to poor outcome on tamoxifen therapy in recurrent breast cancer. | Sci Rep | 2017 | https://conductscience.org/library/papers/28522855 | PubMed |
| 2 | 34548932 | Combined exposure to polychlorinated biphenyls and high-fat diet modifies the global epitranscriptomic landscape in mouse liver. | Environ Epigenet | 2021 | https://conductscience.org/library/papers/34548932 | PubMed |
| 3 | 9270017 | MCF7/LCC9: an antiestrogen-resistant MCF-7 variant in which acquired resistance to the steroidal antiestrogen ICI 182,780 confers an early cross-resistance to the nonsteroidal antiestrogen tamoxifen. | Cancer Res | 1997 | https://conductscience.org/library/papers/9270017 | PubMed |
| 4 | 34108450 | Interactions between m6A modification and miRNAs in malignant tumors. | Cell Death Dis | 2021 | https://conductscience.org/library/papers/34108450 | PubMed |
| 5 | 39252109 | Epitranscriptomics and epigenetics: two sides of the same coin? | Clin Epigenetics | 2024 | https://conductscience.org/library/papers/39252109 | PubMed |
| 6 | 39817679 | Cancer statistics, 2025. | CA Cancer J Clin | 2025 | https://conductscience.org/library/papers/39817679 | PubMed |
| 7 | 39407268 | PSAT1 is upregulated by METTL3 to attenuate high glucose-induced retinal pigment epithelial cell apoptosis and oxidative stress. | Diagn Pathol | 2024 | https://conductscience.org/library/papers/39407268 | PubMed |
| 8 | 36367225 | m6A readers, writers, erasers, and the m6A epitranscriptome in breast cancer. | J Mol Endocrinol | 2023 | https://conductscience.org/library/papers/36367225 | PubMed |
| 9 | 36909339 | The complex nature of heterogeneity and its roles in breast cancer biology and therapeutic responsiveness. | Front Endocrinol (Lausanne) | 2023 | https://conductscience.org/library/papers/36909339 | PubMed |
| 10 | 31479306 | Use of Endocrine Therapy for Breast Cancer Risk Reduction: ASCO Clinical Practice Guideline Update. | J Clin Oncol | 2019 | https://conductscience.org/library/papers/31479306 | PubMed |
| 11 | 27373337 | Structural Basis for Cooperative Function of Mettl3 and Mettl14 Methyltransferases. | Mol Cell | 2016 | https://conductscience.org/library/papers/27373337 | PubMed |
| 12 | 39875975 | CXCR4 promotes tumor stemness maintenance and CDK4/6 inhibitors resistance in ER-positive breast cancer. | Breast Cancer Res | 2025 | https://conductscience.org/library/papers/39875975 | PubMed |
| 13 | 29216929 | PSAT1 is regulated by ATF4 and enhances cell proliferation via the GSK3β/β-catenin/cyclin D1 signaling pathway in ER-negative breast cancer. | J Exp Clin Cancer Res | 2017 | https://conductscience.org/library/papers/29216929 | PubMed |
| 14 | 12184808 | Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. | Genome Biol | 2002 | https://conductscience.org/library/papers/12184808 | PubMed |
| 15 | 28104805 | MicroRNA-145 Modulates N6-Methyladenosine Levels by Targeting the 3'-Untranslated mRNA Region of the N6-Methyladenosine Binding YTH Domain Family 2 Protein. | J Biol Chem | 2017 | https://conductscience.org/library/papers/28104805 | PubMed |
| 16 | 37095185 | RNA modifications in cancer. | Br J Cancer | 2023 | https://conductscience.org/library/papers/37095185 | PubMed |
| 17 | 38211404 | Current and emerging treatment approaches for hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer. | Cancer Treat Rev | 2024 | https://conductscience.org/library/papers/38211404 | PubMed |
| 18 | 38629637 | RNA m6A modification, signals for degradation or stabilisation? | Biochem Soc Trans | 2024 | https://conductscience.org/library/papers/38629637 | PubMed |
| 19 | 39641797 | The role of ceRNAs in breast cancer microenvironmental regulation and therapeutic implications. | J Mol Med (Berl) | 2025 | https://conductscience.org/library/papers/39641797 | PubMed |
| 20 | 31027336 | Preliminary Automated Determination of Edibility of Alternative Foods: Non-Targeted Screening for Toxins in Red Maple Leaf Concentrate. | Plants (Basel) | 2019 | https://conductscience.org/library/papers/31027336 | PubMed |
Genes7
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| HNRNPA2B1 | 3181 | PubTator's text mining | https://conductscience.org/library/genes/3181 | NCBI Gene |
| METTL3 | 56339 | PubTator's text mining | https://conductscience.org/library/genes/56339 | NCBI Gene |
| MIR145 | 406937 | PubTator's text mining | https://conductscience.org/library/genes/406937 | NCBI Gene |
| MIR34B | 407041 | PubTator's text mining | https://conductscience.org/library/genes/407041 | NCBI Gene |
| MYC | 4609 | PubTator's text mining | https://conductscience.org/library/genes/4609 | NCBI Gene |
| PHGDH | 26227 | PubTator's text mining | https://conductscience.org/library/genes/26227 | NCBI Gene |
| PSAT1 | 29968 | PubTator's text mining | https://conductscience.org/library/genes/29968 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41997307
GET https://conductscience.org/api/papers/v1/41997307/references?page=2